Peter Attia· MD
Great news for statin intolerant or ineffective patients.
Loading…
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
Great news for statin intolerant or ineffective patients.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
PCSK9 inhibitors are among the most effective drug classes for lowering high levels of LDL and reducing risk of ASCVD.
um and highly effective in insanely safe zero side effects um cheaper than when they came out uh so they were approved in 2015 um and we have long-term data with the mat people walking around with a natural mutation right just just amazing yeah exactly we have the natural experiment we have all of the data from the drugs um and these these drugs have been tested in really good trials and they've gone head-to-head with every drug and they always win and there's no side effects
the PCS K9 inhibitor y um and highly effective in insanely safe zero side effects